Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 304
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00674557 | Exemestane With or Without ATN-224 in Treating Postmenopausal Women With Recurrent or Advanced Breast Cancer | ||
| NCT02124369 | Pancreatic Resectability in Cancers With Known Limited Extension (PRICKLE) | ||
| NCT03307148 | Stromal TARgeting for PAncreatic Cancer (STAR_PAC) | ||
| NCT03117920 | A Phase II, International Open Label Trial of Minnelide™ in Patients With Refractory Pancreatic Cancer | ||
| NCT07391215 | 5G-PEARL: Paxalisib in Malignant Brain Tumours | ||
| NCT04648033 | Atovaquone With Radical ChemorADIotherapy in Locally Advanced NSCLC | ||
| NCT06632236 | 5G-EMERALD: Amivantamab in Malignant Brain Tumours | ||
| NCT02752204 | An Evaluation AZD2014 Alone and in Combination With Rituximab in Relapsed/Refractory Diffuse Large B Cell Lymphoma | ||
| NCT03728881 | Single Dose of Cervarix Vaccine in Girls or Three Doses of Gardasil Vaccine in Women for the Prevention of Human Papillomavirus Infection, the PRIMAVERA-ESCUDDO Trial | ||
| NCT01561911 | A Phase I Study of the Chimeric Anti-CD40 Monoclonal Antibody ChiLob 7/4 to Treat Advanced Malignancies Refractory to Conventional Anti-cancer Treatment | ||
| NCT01505829 | Diffusion-weighted Imaging Study in Cancer of the Ovary | ||
| NCT00261456 | The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer | ||
| NCT00427713 | Capecitabine and Oxaliplatin or Standard Follow-Up Care in Treating Patients Who Have Undergone Surgery for Locally Advanced Rectal Cancer | ||
| NCT00967889 | Study of Tissue, Blood, and Urine Samples From Patients With Advanced Prostate Cancer | ||
| NCT07279454 | The EAT-FIBRE Study. | ||
| NCT02417662 | Stereotactic Ablative Radiotherapy for Oligometastatic Non-small Cell Lung Cancer | ||
| NCT01431664 | AT9283 in Treating Young Patients With Relapsed or Refractory Acute Leukemia | ||
| NCT02520128 | A Study of IMRT in Primary Bone and Soft Tissue Sarcoma | ||
| NCT02583542 | A Study of AZD2014 in Combination With Selumetinib in Patients With Advanced Cancers | ||
| NCT01737242 | UK Genetic Prostate Cancer Study: Epidemiology and Molecular Genetics Studies | ||
| NCT00006476 | Suramin in Treating Patients With Recurrent Bladder Cancer | ||
| NCT05613023 | A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT | ||
| NCT03096054 | A CR-UK Phase I Trial of LY3143921 | ||
| NCT00072462 | Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ | ||
| NCT01398085 | IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients | ||
| NCT01081288 | Extending the National Health Service (NHS) Breast Screening Age Range | ||
| NCT01881386 | Lactate Imaging as a Tumour Biomarker | ||
| NCT04747665 | Experiences and Perceptions of Colonoscopy and New Technologies | ||
| NCT03527667 | Incentivized Smoking Cessation for Diabetics | ||
| NCT07172958 | Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE) | ||
| NCT02042768 | Observational Study of Glucose Metabolism and How Dialysate Glucose Affects This | ||
| NCT03150576 | Platinum and Polyadenosine 5'Diphosphoribose Polymerisation Inhibitor for Neoadjuvant Treatment of Triple Negative Breast Cancer and/or Germline BRCA Positive Breast Cancer | ||
| NCT04118192 | NOSTRA-Feasibility Study: A Study Looking at Ultrasound Guided Biopsies for Breast Cancer | ||
| NCT03720041 | Myeloma XIV: Frailty-adjusted Therapy in Transplant Non-Eligible Patients With Newly Diagnosed Multiple Myeloma | ||
| NCT04063566 | ReIMAGINE Prostate Cancer Screening | ||
| NCT02758587 | Study of FAK (Defactinib) and PD-1 (Pembrolizumab) Inhibition in Advanced Solid Malignancies (FAK-PD1) | ||
| NCT03245177 | Pembrolizumab in Combination With Radiotherapy in Locally Advanced Non-Small Cell Lung Cancer (NSCLC) | ||
| NCT02768337 | Cambridge Brain Mets Trial 1 | ||
| NCT03529669 | Cytosponge™ for Post-Chemoradiation Surveillance of Oesophageal Cancer | ||
| NCT04717674 | [18F]FPIA PET/CT Imaging in Patients With Solid Tumours | ||
| NCT00411138 | Randomized Trial of Radiation Therapy With or Without Chemotherapy for Endometrial Cancer | ||
| NCT01805375 | A Phase I Trial of DI-B4 in Patients With Advanced CD19 Positive Indolent B-cell Malignancies | ||
| NCT00275132 | Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | ||
| NCT01222221 | Vaccine Therapy, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | ||
| NCT07209774 | Healthspan Connect Programme of Research | ||
| NCT03294434 | Predicting Sites of Tumour Progression in the Invasive Margin of Glioblastomas (PRaM-GBM Study) | ||
| NCT00678327 | Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma | ||
| NCT05770544 | DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers. | ||
| NCT05830292 | Use of DRS Probe and Tracking for In-vivo Application | ||
| NCT00032175 | Gemcitabine With or Without Capecitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer |
